Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07035002
What this trial is testing

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)Tumor Infiltrating LymphocytesPD-1
Ruijin Hospital 29
Large-scale testing (Phase 3)Study completedNCT03134872
What this trial is testing

SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more
Jiangsu HengRui Medicine Co., Ltd. 419
Testing effectiveness (Phase 2)Looking for participantsNCT07279077
What this trial is testing

Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial

Who this might be right for
Colon CancerNeoadjuvant TherapiesImmune Checkpoint Therapy+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 38
Testing effectiveness (Phase 2)UnknownNCT05749575
What this trial is testing

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

Who this might be right for
Breast Cancer
Sun Yat-sen University 28
Not applicableStudy completedNCT05775705
What this trial is testing

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Who this might be right for
PD-1 AntibodyHemophagocytic LymphohistiocytosisEpstein-Barr Virus+1 more
Beijing Friendship Hospital 24
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649980
What this trial is testing

Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II

Who this might be right for
Biliary Tract Cancer (BTC)EGFR-positive Advanced Biliary Tract Carcinoma
HuiKai Li 30
Testing effectiveness (Phase 2)Looking for participantsNCT06468280
What this trial is testing

Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Shanghai Zhongshan Hospital 84
Testing effectiveness (Phase 2)Looking for participantsNCT07001618
What this trial is testing

Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Gustave Roussy, Cancer Campus, Grand Paris 162
Testing effectiveness (Phase 2)Looking for participantsNCT06107374
What this trial is testing

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

Who this might be right for
Advanced Non Small Cell Lung Cancer
CellSight Technologies, Inc. 20
Early research (Phase 1)WithdrawnNCT02863913
What this trial is testing

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Who this might be right for
Invasive Bladder Cancer Stage IV
Peking University
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Testing effectiveness (Phase 2)Ended earlyNCT05581719
What this trial is testing

A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Who this might be right for
Solid TumorPeritoneal MetastasesPeritoneal Cancer
Enlivex Therapeutics RDO Ltd. 14
Testing effectiveness (Phase 2)UnknownNCT06543836
What this trial is testing

CtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Testing effectiveness (Phase 2)UnknownNCT05962450
What this trial is testing

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 84
Not applicableNot Yet RecruitingNCT06607926
What this trial is testing

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Who this might be right for
Resectable Non-Small-Cell Lung Cancer
Xuanwu Hospital, Beijing 40
Large-scale testing (Phase 3)UnknownNCT04084626
What this trial is testing

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

Who this might be right for
EBV Infection
Beijing Friendship Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06492408
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

Who this might be right for
Hepatic CancerSurgery
Second Affiliated Hospital of Guangzhou Medical University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678580
What this trial is testing

Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 50
Large-scale testing (Phase 3)Study completedNCT02973789
What this trial is testing

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Who this might be right for
Nonsmall Cell Lung CancerNSCLC
NovoCure GmbH 291
Next Page